Novo Nordisk A/S (NVO) Earnings Yield: 9.82%
Is Novo Nordisk A/S’s earnings yield high or low?
Novo Nordisk A/S's earnings yield of 9.82% is 160% above its 5-year average of 3.78%, near the high end of its 5-year range (1.96%–10.42%).
As of Wednesday, June 17, 2026. 33.00% above its 12-month average of 7.38%.
NVO Earnings Yield Chart
NVO Average Earnings Yield Chart
NVO Current vs Average Earnings Yield Chart
NVO Earnings Yield Metrics
EARNINGS YIELD
9.82%
EARNINGS YIELD AVG TTM
7.38%
EARNINGS YIELD AVG 3Y
4.37%
EARNINGS YIELD AVG 5Y
3.16%
EARNINGS YIELD AVG 10Y
4.11%
EARNINGS YIELD AVG 15Y
4.01%
EARNINGS YIELD AVG 20Y
4.10%
CURRENT VS TTM AVG
+33.00%
CURRENT VS 3Y AVG
+124.69%
CURRENT VS 5Y AVG
+210.81%
CURRENT VS 10Y AVG
+138.73%
CURRENT VS 15Y AVG
+144.80%
CURRENT VS 20Y AVG
+139.41%
NVO Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $193.39B | 9.82% | 7.38% | 4.37% | 3.16% |
| Amgen Inc. (AMGN)vs › | $187.59B | 4.13% | 4.01% | 3.82% | 4.18% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $175.64B | 3.85% | 3.47% | 3.14% | 3.26% |
| Gilead Sciences, Inc. (GILD)vs › | $158.06B | 5.77% | 4.76% | 3.69% | 4.39% |
| Abbott Laboratories (ABT)vs › | $157.84B | 3.96% | 5.47% | 4.06% | 3.87% |
| Pfizer Inc. (PFE)vs › | $148.41B | 5.03% | 6.27% | 6.33% | 7.46% |
| Intuitive Surgical, Inc. (ISRG)vs › | $145.70B | 1.98% | 1.55% | 1.36% | 1.44% |
| Danaher Corporation (DHR)vs › | $128.06B | 2.85% | 2.44% | 2.71% | 3.03% |
| CVS Health Corporation (CVS)vs › | $127.73B | 2.25% | 2.85% | 5.89% | 5.69% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $116.49B | 3.67% | 3.41% | 3.43% | 3.72% |
Earnings Yield vs P/E Ratio
Earnings Yield
9.82%
EPS ÷ Price
P/E Ratio
10.2
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Novo Nordisk A/S Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Novo Nordisk A/S Earnings Yield FAQ
- What is the earnings yield for Novo Nordisk A/S (NVO)?
- The earnings yield for NVO stock is 9.82%.
- Is Novo Nordisk A/S's earnings yield high or low?
- Novo Nordisk A/S's earnings yield of 9.82% is 160% above its 5-year average of 3.78%, near the high end of its 5-year range (1.96%–10.42%).
- What is the TTM average earnings yield for Novo Nordisk A/S (NVO)?
- The TTM average earnings yield for NVO stock is 7.38%.
- What is the 3Y average earnings yield for Novo Nordisk A/S (NVO)?
- The 3Y average earnings yield for NVO stock is 4.37%.
- What is the 5Y average earnings yield for Novo Nordisk A/S (NVO)?
- The 5Y average earnings yield for NVO stock is 3.16%.
- What is the 10Y average earnings yield for Novo Nordisk A/S (NVO)?
- The 10Y average earnings yield for NVO stock is 4.11%.
- What is the 15Y average earnings yield for Novo Nordisk A/S (NVO)?
- The 15Y average earnings yield for NVO stock is 4.01%.
- What is the 20Y average earnings yield for Novo Nordisk A/S (NVO)?
- The 20Y average earnings yield for NVO stock is 4.10%.
Novo Nordisk A/S Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-17 | 9.82% |
| 2026-06-16 | 9.81% |
| 2026-06-15 | 9.74% |
| 2026-06-12 | 9.74% |
| 2026-06-11 | 9.73% |
| 2026-06-10 | 9.98% |
| 2026-06-09 | 10.13% |
| 2026-06-08 | 10.42% |
| 2026-06-05 | 9.95% |
| 2026-06-04 | 9.77% |
| 2026-06-03 | 10.17% |
| 2026-06-02 | 9.96% |
| 2026-06-01 | 9.70% |
| 2026-05-29 | 9.38% |
| 2026-05-28 | 9.39% |
| 2026-05-27 | 9.60% |
| 2026-05-26 | 9.67% |
| 2026-05-22 | 9.51% |
| 2026-05-21 | 9.63% |
| 2026-05-20 | 9.49% |
| 2026-05-19 | 9.65% |
| 2026-05-18 | 9.65% |
| 2026-05-15 | 9.55% |
| 2026-05-14 | 9.34% |
| 2026-05-13 | 9.08% |
| 2026-05-12 | 9.09% |
| 2026-05-11 | 9.21% |
| 2026-05-08 | 9.28% |
| 2026-05-07 | 9.34% |
| 2026-05-06 | 9.34% |
| 2026-05-05 | 7.89% |
| 2026-05-04 | 7.97% |
| 2026-05-01 | 8.06% |
| 2026-04-30 | 8.38% |
| 2026-04-29 | 8.78% |
| 2026-04-28 | 8.59% |
| 2026-04-27 | 8.59% |
| 2026-04-24 | 8.59% |
| 2026-04-23 | 9.18% |
| 2026-04-22 | 9.04% |
| 2026-04-21 | 8.98% |
| 2026-04-20 | 8.75% |
| 2026-04-17 | 8.73% |
| 2026-04-16 | 8.64% |
| 2026-04-15 | 8.67% |
| 2026-04-14 | 9.00% |
| 2026-04-13 | 9.32% |
| 2026-04-10 | 9.43% |
| 2026-04-09 | 9.45% |
| 2026-04-08 | 9.41% |
| 2026-04-07 | 9.59% |
| 2026-04-06 | 9.65% |
| 2026-04-02 | 9.57% |
| 2026-04-01 | 9.70% |
| 2026-03-31 | 9.62% |
| 2026-03-30 | 10.03% |
| 2026-03-27 | 9.81% |
| 2026-03-26 | 9.72% |
| 2026-03-25 | 9.74% |
| 2026-03-24 | 9.59% |
| 2026-03-23 | 9.61% |
| 2026-03-20 | 9.69% |
| 2026-03-19 | 9.54% |
| 2026-03-18 | 9.45% |
| 2026-03-17 | 9.21% |
| 2026-03-16 | 9.17% |
| 2026-03-13 | 9.32% |
| 2026-03-12 | 9.30% |
| 2026-03-11 | 9.12% |
| 2026-03-10 | 9.14% |
| 2026-03-09 | 8.90% |
| 2026-03-06 | 9.17% |
| 2026-03-05 | 9.06% |
| 2026-03-04 | 9.19% |
| 2026-03-03 | 9.65% |
| 2026-03-02 | 9.37% |
| 2026-02-27 | 9.45% |
| 2026-02-26 | 9.41% |
| 2026-02-25 | 9.28% |
| 2026-02-24 | 9.17% |
| 2026-02-23 | 8.93% |
| 2026-02-20 | 7.46% |
| 2026-02-19 | 7.30% |
| 2026-02-18 | 7.19% |
| 2026-02-17 | 7.17% |
| 2026-02-13 | 7.14% |
| 2026-02-12 | 7.23% |
| 2026-02-11 | 7.26% |
| 2026-02-10 | 7.20% |
| 2026-02-09 | 7.17% |
| 2026-02-06 | 7.43% |
| 2026-02-05 | 8.16% |
| 2026-02-04 | 7.50% |
| 2026-02-03 | 7.03% |
| 2026-02-02 | 5.88% |
| 2026-01-30 | 5.83% |
| 2026-01-29 | 5.84% |
| 2026-01-28 | 5.75% |
| 2026-01-27 | 5.51% |
| 2026-01-26 | 5.42% |
| 2026-01-23 | 5.57% |
| 2026-01-22 | 5.57% |
| 2026-01-21 | 5.84% |
| 2026-01-20 | 5.71% |
| 2026-01-16 | 5.56% |
| 2026-01-15 | 6.07% |
| 2026-01-14 | 5.89% |
| 2026-01-13 | 5.81% |
| 2026-01-12 | 5.79% |
| 2026-01-09 | 5.90% |
| 2026-01-08 | 6.05% |
| 2026-01-07 | 6.13% |
| 2026-01-06 | 6.16% |
| 2026-01-05 | 6.29% |
| 2026-01-02 | 6.62% |
| 2025-12-31 | 6.81% |
| 2025-12-30 | 6.77% |
| 2025-12-29 | 6.73% |
| 2025-12-26 | 6.61% |
| 2025-12-24 | 6.60% |
| 2025-12-23 | 6.72% |
| 2025-12-22 | 7.21% |
| 2025-12-19 | 7.21% |
| 2025-12-18 | 7.28% |
| 2025-12-17 | 7.26% |
| 2025-12-16 | 7.08% |
| 2025-12-15 | 6.88% |
| 2025-12-12 | 6.91% |
| 2025-12-11 | 6.89% |
| 2025-12-10 | 7.07% |
| 2025-12-09 | 7.48% |
| 2025-12-08 | 7.41% |
| 2025-12-05 | 7.24% |
| 2025-12-04 | 7.23% |
| 2025-12-03 | 7.29% |
| 2025-12-02 | 7.31% |
| 2025-12-01 | 7.16% |
| 2025-11-28 | 7.02% |
| 2025-11-26 | 7.12% |
| 2025-11-25 | 7.37% |
| 2025-11-24 | 7.71% |
| 2025-11-21 | 7.28% |
| 2025-11-20 | 7.28% |
| 2025-11-19 | 7.08% |
| 2025-11-18 | 7.29% |
| 2025-11-17 | 7.15% |
| 2025-11-14 | 7.18% |
| 2025-11-13 | 7.05% |
| 2025-11-12 | 6.90% |
| 2025-11-11 | 7.05% |
| 2025-11-10 | 7.55% |
| 2025-11-07 | 7.59% |
| 2025-11-06 | 7.45% |
| 2025-11-05 | 7.15% |
| 2025-11-04 | 7.62% |
| 2025-11-03 | 7.48% |
| 2025-10-31 | 7.43% |
| 2025-10-30 | 7.34% |
| 2025-10-29 | 7.15% |
| 2025-10-28 | 7.06% |
| 2025-10-27 | 6.95% |
| 2025-10-24 | 6.94% |
| 2025-10-23 | 6.90% |
| 2025-10-22 | 6.88% |
| 2025-10-21 | 6.71% |
| 2025-10-20 | 6.59% |
| 2025-10-17 | 6.76% |
| 2025-10-16 | 6.55% |
| 2025-10-15 | 6.48% |
| 2025-10-14 | 6.49% |
| 2025-10-13 | 6.39% |
| 2025-10-10 | 6.46% |
| 2025-10-09 | 6.26% |
| 2025-10-08 | 6.17% |
| 2025-10-07 | 6.23% |
| 2025-10-06 | 6.16% |
| 2025-10-03 | 6.16% |
| 2025-10-02 | 6.25% |
| 2025-10-01 | 6.21% |
| 2025-09-30 | 6.62% |
| 2025-09-29 | 6.62% |
| 2025-09-26 | 6.61% |
| 2025-09-25 | 6.56% |
| 2025-09-24 | 6.25% |
| 2025-09-23 | 6.17% |
| 2025-09-22 | 6.05% |
| 2025-09-19 | 5.98% |
| 2025-09-18 | 5.94% |
| 2025-09-17 | 6.31% |
| 2025-09-16 | 6.42% |
| 2025-09-15 | 6.61% |
| 2025-09-12 | 6.70% |
| 2025-09-11 | 6.77% |
| 2025-09-10 | 6.76% |
| 2025-09-09 | 6.77% |
| 2025-09-08 | 6.77% |
| 2025-09-05 | 6.65% |
| 2025-09-04 | 6.54% |
| 2025-09-03 | 6.48% |
| 2025-09-02 | 6.52% |
| 2025-08-29 | 6.51% |
| 2025-08-28 | 6.55% |
| 2025-08-27 | 6.51% |
| 2025-08-26 | 6.64% |
| 2025-08-25 | 6.52% |
| 2025-08-22 | 6.45% |
| 2025-08-21 | 6.63% |
| 2025-08-20 | 6.77% |
| 2025-08-19 | 6.71% |
| 2025-08-18 | 6.84% |
| 2025-08-15 | 7.01% |
| 2025-08-14 | 7.21% |
| 2025-08-13 | 7.22% |
| 2025-08-12 | 7.38% |
| 2025-08-11 | 7.37% |
| 2025-08-08 | 7.19% |
| 2025-08-07 | 7.54% |
| 2025-08-06 | 8.10% |
| 2025-08-05 | 7.16% |
| 2025-08-04 | 6.93% |
| 2025-08-01 | 7.02% |
| 2025-07-31 | 7.18% |
| 2025-07-30 | 6.76% |
| 2025-07-29 | 6.27% |
| 2025-07-28 | 4.90% |
| 2025-07-25 | 4.72% |
| 2025-07-24 | 4.78% |
| 2025-07-23 | 4.83% |
| 2025-07-22 | 5.06% |
| 2025-07-21 | 5.21% |
| 2025-07-18 | 5.26% |
| 2025-07-17 | 5.18% |
| 2025-07-16 | 5.05% |
| 2025-07-15 | 5.03% |
| 2025-07-14 | 4.91% |
| 2025-07-11 | 4.91% |
| 2025-07-10 | 4.76% |
| 2025-07-09 | 4.85% |
| 2025-07-08 | 4.86% |
| 2025-07-07 | 4.88% |
| 2025-07-03 | 4.89% |
| 2025-07-02 | 4.84% |
| 2025-07-01 | 4.84% |
| 2025-06-30 | 4.90% |
| 2025-06-27 | 4.94% |
| 2025-06-26 | 5.00% |
| 2025-06-25 | 5.02% |
| 2025-06-24 | 4.78% |
| 2025-06-23 | 4.85% |
| 2025-06-20 | 4.59% |
| 2025-06-18 | 4.57% |
| 2025-06-17 | 4.55% |
| 2025-06-16 | 4.39% |
| 2025-06-13 | 4.24% |
| 2025-06-12 | 4.17% |
| 2025-06-11 | 4.30% |
| 2025-06-10 | 4.26% |
| 2025-06-09 | 4.48% |
| 2025-06-06 | 4.53% |
| 2025-06-05 | 4.66% |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Novo Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Maziar Mike Doustdar